My main question revolves around the relevance of my data sets whilst using SoftSV. SoftSV is seen to use whole genome sequencing data, however my data sets revolve around targeted panels around chromosome 11 and chromosome 14. Would you know of SoftSV's relevance with using targeted panel data, or if it has been used before? If so, was there any different effects seen in this in comparison to whole genome data sets?
I believe that this shouldn't be an issue, however I thought contacting the author would be more beneficial before applying the data to the development. Let me know what you think and any help regarding this would be greatly appreciated.
If you would like to refer to this comment somewhere else in this project, copy and paste the following link:
My main question revolves around the relevance of my data sets whilst using SoftSV. SoftSV is seen to use whole genome sequencing data, however my data sets revolve around targeted panels around chromosome 11 and chromosome 14. Would you know of SoftSV's relevance with using targeted panel data, or if it has been used before? If so, was there any different effects seen in this in comparison to whole genome data sets?
I believe that this shouldn't be an issue, however I thought contacting the author would be more beneficial before applying the data to the development. Let me know what you think and any help regarding this would be greatly appreciated.